EAM
ACOR
Eagle Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-938,871
| Closed | -$17.7M | – | 680 |
|
2016
Q4 | $17.7M | Sell |
938,871
-693,020
| -42% | -$13M | 0.12% | 240 |
|
2016
Q3 | $34.1M | Buy |
1,631,891
+40,153
| +3% | +$839K | 0.23% | 136 |
|
2016
Q2 | $40.6M | Sell |
1,591,738
-73,507
| -4% | -$1.88M | 0.28% | 113 |
|
2016
Q1 | $44M | Sell |
1,665,245
-123,320
| -7% | -$3.26M | 0.31% | 104 |
|
2015
Q4 | $76.5M | Sell |
1,788,565
-158,419
| -8% | -$6.78M | 0.51% | 43 |
|
2015
Q3 | $51.6M | Sell |
1,946,984
-423,010
| -18% | -$11.2M | 0.35% | 92 |
|
2015
Q2 | $79M | Sell |
2,369,994
-91,986
| -4% | -$3.07M | 0.44% | 70 |
|
2015
Q1 | $81.9M | Sell |
2,461,980
-129,782
| -5% | -$4.32M | 0.47% | 61 |
|
2014
Q4 | $106M | Buy |
2,591,762
+119,291
| +5% | +$4.87M | 0.61% | 36 |
|
2014
Q3 | $83.8M | Buy |
2,472,471
+80,978
| +3% | +$2.74M | 0.48% | 59 |
|
2014
Q2 | $80.6M | Buy |
2,391,493
+281,901
| +13% | +$9.5M | 0.44% | 68 |
|
2014
Q1 | $80M | Sell |
2,109,592
-3,399
| -0.2% | -$127K | 0.44% | 54 |
|
2013
Q4 | $61.7M | Sell |
2,112,991
-101,526
| -5% | -$2.96M | 0.35% | 91 |
|
2013
Q3 | $76.9M | Buy |
2,214,517
+177,074
| +9% | +$6.15M | 0.38% | 75 |
|
2013
Q2 | $67.2M | Buy |
+2,037,443
| New | +$67.2M | 0.45% | 54 |
|